Industry: Pharmaceuticals, Biotechnology
Originally founded as Innapharma in 1989, Tetragenex Pharmaceuticals Inc. is a privately held biopharmaceutical company working to discover, develop and commercialize proprietary pharmaceutical products that treat serious diseases for which current therapies are inadequate. Since 1990, we have synthesized and patented a novel platform of pharmaceutical “small chain” peptides that treat depression, and may treat anxiety and other central nervous system disorders. Our lead antidepressant compound, Nemifitide (INN 00835), is currently in Phase 2 / 3 human clinical trials. Our objective is to become a fully integrated pharmaceutical company, primarily through our expertise in the identification, acquisition and development of pharmaceutical products and ( www.tetragenex.com )
Tetragenex Pharmaceuticals , Inc
1 Maynard Drive Suite 205
Park Ridge, New Jersey 07656
USA
Tel: (201) 505-1300
Fax: (201) 505-1501